본문 바로가기

Limited Predictive Value of Dual-Time-Point F-18 FDG PET/CT for Evaluation of Pathologic N1 Status in NSCLC Patients

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
저널
CLINICAL NUCLEAR MEDICINE36(6) · pp.434 · 2011
피인용
Web of Science 18
JCR IF
JCR 2010 3.766
ISSN
0363-9762

저자

  1. 김성장제1저자부산대학교, 의과대학, 의과학과, 내과학교실, KO
  2. Kim, Yong-KiPrivate Clin Endocrinol & Metab & Nucl Med, KO
  3. 김인주부산대학교, 의과대학, 의학과, KO
  4. 김영대부산대학교, 의과대학, 의학과, KO
  5. 이민기부산대학교, 의과대학, 의학과, KO

초록

Objective: The aim of the current study was to investigate the predictive value of dual-time-point F-18 FDG PET/CT for pathologic N1 metastasis in patients with non-small cell lung cancer (NSCLC). Methods: A retrospective review identified 70 patients with NSCLC patients who received dual-time-point F-18 FDG PET/CT at diagnosis of cancer. The F-18 FDG PET/CT findings for all primary NSCLC and mediastinal lymph node involvement were compared with the pathologic diagnosis within 5 weeks after surgical resection. The pathologic diagnoses of N1 state were confirmed by surgical resection. Univariate and multivariate analyses were used to analyze the associations among the pathologic N1 status and age, sex, tumor size, histology, standardized uptake value (SUVmaxE), SUVmaxD, and %Delta SUVmax. Results: The N1 (+) group showed statistically significant higher value of SUVmaxE and SUVmaxD than N1 (-) group. The %Delta SUVmax did not show the statistical difference between pathologic N1 (+) and N1 (-) groups. Receiver operating characteristic analyses showed that the SUVmaxE was superior to the %Delta SUVmax for the prediction of pathologic N1 involvement in NSCLC. In univariate analysis, pathology (adenocarcinoma or nonadeno-carcinoma), SUVmaxE (>6.9 or <= 6.9), SUVmaxD (>7.1 or <= 7.1) were factors significantly associated with pathologic N1 involvement. However, in multivariate analysis, only the SUVmaxE was factor significantly associated with pathologic N1 involvement in NSCLC. Conclusions: Based on the presented results, the dual-time-point F-18 FDG PET/CT is not a useful method for the prediction of pathologic N1 status in NSCLC patients. Further studies are needed to confirm these results and improve statistical accuracy.

키워드

F-18 FDG PET/CTdual-time-point imagingNSCLClymph nodeCELL LUNG-CANCERPOSITRON-EMISSION-TOMOGRAPHYPULMONARY NODULESLYMPH-NODESDIAGNOSIS

식별자

WoS UID
000290300300008